Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Malignancies × repaglinide × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

TP53 Y220C Mutation 1 Healthy Adult Participants 1 Advanced Malignancies 1

Interventions

Midazolam 2 zanidatamab 1 tislelizumab 1 sitravatinib 1 repaglinide 1 pamiparib 1 lenvatinib 1 drospirenone 1 cemiplimab 1 Temozolomide 1 Pemetrexed 1 Paclitaxel 1 Ipilimumab 1 Injections 1 HMPL-013 1 Gemcitabine 1 Ethinyl Estradiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07340190 2026-01-14

A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies

Novartis

Phase 1 Not yet recruiting

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡